TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
CADL

Candel Therapeutics Inc

Healthcare · Biotechnology

11.00$ -4.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow CADL
Line item 2019 2020 2021 2022 2023 2024 2025
-4,141.6% -7,256.8% -17,774.4% -25,135.2% -110,464.5% – –
34.4% 72.8% 185.6% 622.4% 3,096.8% – –
320.0% 1,685.6% 2,370.4% 1,845.6% 9,971.0% – –
2,005.6% 5,395.2% 11,568.0% -11,012.0% – – –
410.4% 1,419.2% -700.8% 56.8% -1,693.5% – –
127.2% 1,180.8% 1,468.0% 1,037.6% 1,474.2% – –
-28,592.8% 30,764.0% -1,468.0% -1,037.6% -903.2% – –
– – 57,440.0% – -390.3% – –
-417.6% 368.0% 15,928.0% 15,928.0% 0.0% – –
17,583.2% 392.0% 57,440.0% 15,979.2% -390.3% – –
-15,151.2% 23,899.2% 38,197.6% -10,193.6% -111,758.1% – –
-4,268.8% -8,437.6% -19,242.4% -26,172.8% -111,938.7% – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?